Integrated BioPharma Valuation

Q: What is the Fair Price of INBP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

INBP ($0.32) is trading above our estimate of [[fair value]] ($0.19)

Is INBP undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of INBP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: INBP ($0.32) is trading above our estimate of fair value ($0.19)

Significantly Below Fair Value: INBP is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for INBP?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for INBP. This is calculated by dividing INBP's market cap by their current preferred multiple.
What is INBP's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	US$9.63m

INBP key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.2x
Enterprise Value/EBITDA	17.1x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does INBP's PE Ratio compare to its peers?

The above table shows the PE ratio for INBP vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	35.9x
DQWS DSwiss	22.9x	n/a	US$4.1m
UG United-Guardian	18x	n/a	US$58.9m
SNYR Synergy CHC	11.5x	n/a	US$61.1m
NHTC Natural Health Trends	91.2x	n/a	US$68.9m
INBP Integrated BioPharma	86x	n/a	US$9.6m

Price-To-Earnings vs Peers: INBP is expensive based on its Price-To-Earnings Ratio (86x) compared to the peer average (35.9x).

Price to Earnings Ratio vs Industry

How does INBP's PE Ratio compare vs other companies in the US Personal Products Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	25.3%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	25.3%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: INBP is expensive based on its Price-To-Earnings Ratio (86x) compared to the North American Personal Products industry average (24.9x).

Price to Earnings Ratio vs Fair Ratio

What is INBP's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

INBP PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	86x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate INBP's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.